1 / 5

Endonasal Removal of Invasive GH-Secreting Adenoma (Acromegaly)

Endonasal Removal of Invasive GH-Secreting Adenoma (Acromegaly). Acromegaly: Clinical History:. 49 yr man with 10 years of snoring, sleep apnea, coarsened facial features, frontal bossing & prognathism 5 years progressive enlargement of hands & feet 1 year worsening vision

jolie-farley
Download Presentation

Endonasal Removal of Invasive GH-Secreting Adenoma (Acromegaly)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Endonasal Removal of Invasive GH-Secreting Adenoma (Acromegaly)

  2. Acromegaly: Clinical History: • 49 yr man with 10 years of snoring, sleep apnea, coarsened facial features, frontal bossing & prognathism • 5 years progressive enlargement of hands & feet • 1 year worsening vision • 6 months hypertension & hypercholesterolemia • Hormonal tests: Growth hormone 179 ng/ml (normal < 6); IGF-1 1508 ng/ml, prolactin 184 ng/ml. 1992 1996 2001 2006

  3. Acromegaly: MRI Pre-op MRI shows invasive adenoma with left cavernous sinus and clival invasion. Treated with pre-operative octreotide therapy for 3 weeks then removed by endonasal surgery in near-complete fashion.

  4. Video - Acromegaly

  5. Acromegaly Post-operative course: • Adenoma removed in near-complete fashion. • Post-op GH level decreased from 179 to 1 ng/ml; prolactin 2 ng/ml. • Patient much improved symptomatically but will need additional therapy (octreotide and/or radiotherapy) for remaining tumor in left cavernous sinus & clivus.

More Related